• AG-120 (Ivosidenib): Selective Mutant IDH1 Inhibitor for AML

  2026-05-05

  AG-120 (Ivosidenib) is a potent, selective inhibitor of mutant IDH1 used in AML research. It reduces 2-hydroxyglutarate levels and restores myeloid differentiation, demonstrating translational value for IDH1-mutant malignancies.

• Mdivi-1: Selective DRP1 Inhibitor for Mitochondrial Dynamics

  2026-05-04

  Mdivi-1 is a selective DRP1 inhibitor that blocks mitochondrial fission and attenuates intrinsic apoptosis. This compound enables precise mitochondrial dynamics research and neuroprotection studies. Its validated performance in apoptosis assays and ischemic retinal models is benchmarked by robust, peer-reviewed evidence.

• Fasudil (HA-1077) HCl: ROCK Inhibitor for Cell Migration Stu

  2026-05-04

  Fasudil (HA-1077) HCl from APExBIO empowers researchers to dissect Rho/ROCK pathway inhibition with precision, offering robust control over cell migration, proliferation, and apoptosis in both cancer and hematology models. Its superior solubility, distinct selectivity profile, and protocol-ready formulation accelerate experimental workflows and troubleshooting.

• Triiodothyronine (T3): Reliable Data for Cell Assay Excellen

  2026-05-03

  Explore how Triiodothyronine (SKU C6407) addresses critical challenges in cell viability, proliferation, and metabolic regulation assays. This evidence-driven guide helps biomedical scientists achieve reproducible, high-sensitivity data by leveraging the high-purity, well-documented performance of Triiodothyronine from APExBIO.

• AMH-SMAD4 Axis Modulates Granulosa Cell Fate in PCOS Rat Mod

  2026-05-02

  This study uncovers how anti-Müllerian hormone (AMH) regulates ovarian granulosa cell proliferation and apoptosis via the SMAD4 pathway in a rat model of polycystic ovary syndrome (PCOS). The findings provide mechanistic insight into follicular dysfunction in PCOS and suggest new cellular targets for research into ovulatory disorders.

• Enhancing Cell Assay Reliability with DiscoveryProbe™ FDA-ap

  2026-05-02

  This article addresses persistent assay design and reproducibility challenges in cell viability, proliferation, and cytotoxicity workflows. By anchoring real-world laboratory scenarios, it demonstrates how DiscoveryProbe™ FDA-approved Drug Library (SKU: L1021) delivers reproducible, high-content screening for drug repositioning, target identification, and disease modeling. Practical Q&A blocks guide biomedical researchers in optimizing protocols, interpreting data, and making informed product choices using SKU L1021.

• Triiodothyronine (T3): Accelerating Translational Adipocyte

  2026-05-01

  Explore how Triiodothyronine (T3) empowers translational researchers to dissect thyroid hormone signaling pathways, illuminate the mechanistic interface with adipocyte thermogenesis, and bridge metabolic regulation from bench to clinic. This article uniquely synthesizes recent SEMA3E-β-catenin findings with practical guidance for deploying APExBIO’s high-purity T3 in advanced metabolic models, providing evidence-labeled insights and actionable recommendations.

• GANT61 GLI Inhibitor: Precision Workflows for Tumor Suppress

  2026-04-30

  GANT61 offers targeted, selective inhibition of GLI1/2, enabling researchers to dissect Hedgehog pathway-driven oncogenesis and immune evasion. This guide delivers stepwise protocols, advanced troubleshooting, and cutting-edge insights from recent immune resistance research, ensuring robust and reproducible results in cancer biology.

• Nonivamide (Capsaicin Analog): Assay Optimization and TRPV1-

  2026-04-30

  Explore the unique roles of Nonivamide, a potent capsaicin analog, in optimizing TRPV1-targeted assays and modulating inflammation. This article provides advanced protocol guidance and practical insights for cancer and neuroimmune research, distinguishing itself with an in-depth focus on experimental design and translational impact.

• M344 HDAC Inhibitor: Precision Epigenetics in Cancer and HIV

  2026-04-29

  Discover how the potent histone deacetylase inhibitor M344 enables next-generation precision in epigenetic research, with unique insights into protocol design, toxicity, and translational impact for cancer and HIV latency studies.

• Amphotericin B: Optimizing Polyene Antifungal Antibiotic Wor

  2026-04-29

  Amphotericin B, a polyene antifungal antibiotic, sets the benchmark for reliable fungal infection research by targeting membrane sterols with quantifiable potency. This article delivers actionable workflow enhancements, evidence-based troubleshooting, and expert protocol parameters—empowering researchers to maximize reproducibility and data quality using APExBIO’s trusted product.

• RWJ 67657: Decoding Selective p38 MAPK Inhibition Dynamics

  2026-04-28

  Explore how RWJ 67657 (JNJ-3026582) advances selective p38α/β MAP kinase inhibition for inflammatory disease research. This article uniquely connects conformational control insights with practical assay optimization.

• IWR-1-endo: Precision Wnt Pathway Inhibition for Translation

  2026-04-28

  This thought-leadership article bridges mechanistic insight and strategic guidance for translational researchers leveraging IWR-1-endo—a nanomolar-potency Wnt signaling inhibitor—for colorectal cancer and regenerative biology. By unpacking the nuances of Axin-scaffolded destruction complex stabilization and benchmarking IWR-1-endo against evolving experimental needs, we integrate recent advances in single-nucleus profiling, highlight practical workflows, and delineate how this approach advances the field beyond standard tools and product pages.

• CasKAS Enables Direct Genome-Wide Profiling of CRISPR Specif

  2026-04-27

  The CasKAS assay, introduced by Marinov et al., provides a rapid and cost-effective method for direct genome-wide mapping of off-target activity by both active and dead Cas9 proteins via ssDNA detection. This approach addresses key limitations of prior methods, offering improved applicability and technical accessibility for CRISPR specificity assessment.

• AO/PI Double Staining Kit: Precision Cell Viability & Apopto

  2026-04-27

  The AO/PI Double Staining Kit from APExBIO enables rapid, multiplexed assessment of cell viability, apoptosis, and necrosis using dual fluorescent staining—empowering researchers to dissect cell fate in complex samples. Its robust workflow, validated in translational and high-sensitivity settings, provides clear differentiation and actionable insights, even for rare cell populations.

447 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page